Medical Devices and Diagnostic Industries announced a keynote panel discussion at BIOMedevice Boston to occur on Thu, Sep 29, 2022. Six female medical device industry executives will team up to talk about innovations in digital health solutions, Artificial Intelligence, and the regulatory challenges these innovations may face. The event will be moderated by Maria Shepherd, president of Medi-Vantage and co-founder of MedExecWomen. The panel, with Shepherd moderating, includes Jill Dooling, vice president of Strategic Accounts at Vapotherm, Sara Kehoe, Senior Director, Clinical Insights at Danaher Diagnostics, Teresa Prego, Chief Commercial Officer at Nile, Mira Sahney, President, Pelvic Health at Medtronic, and Jill Schiaparelli, CEO at Avation Medical. The session, sponsored by MedExec Women, will be held Thursday, Sept. 29, from 9:15 to 10:15 a.m. on the Center Stage.
About Avation Medical
Avation Medical is an innovative advanced neuromodulation and digital health company pioneering closed-loop, patient-friendly, wearable neuromodulation therapies that deliver personalized therapy based on the patient’s own physiologic response. The Company’s intelligent wearable therapies objectively confirm activation of the target nerve and make neuromodulation technology accessible to millions of patients across a variety of clinical applications by eliminating the need for surgery, needles and permanent implants and shifting therapy into the home environment.
The Company’s wearable bladder therapy and digital health system is available for investigational use only and is not FDA cleared.